Public transit and methadone - Spatial analyses of opioid treatment program access in Greater Boston, 2020-2022

公共交通与美沙酮——2020-2022年大波士顿地区阿片类药物治疗项目可及性的空间分析

阅读:1

Abstract

OBJECTIVE: Methadone, an FDA-approved medication, can effectively treat opioid use disorder (OUD). However, long travel times to opioid treatment programs (OTPs) commonly present barriers to initiating and continuing methadone treatment. We utilized geographic information systems to identify areas with unmet OTP access needs via public transportation and walking in Boston, Massachusetts. METHODS: We created public transit-time and walk-time catchment areas around OTPs. We assessed spatial overlap between the catchment areas and locations of opioid-related overdose decedent residences from 2020 to 2022 in Boston, and inequities in OTP access by decedent race/ethnicity using logistic regression. RESULTS: In Greater Boston, 50.1% of fatal opioid-related overdose decedent residences were within 30 min of an OTP via public transit at the time of death. In Boston, 80.4% of fatal opioid-related overdose decedent residences were within 30-min transit times of an OTP. In the early morning, access to OTPs on public transit is limited. Differences in OTP access based on decedent race/ethnicity were inconsistent. CONCLUSION: Many areas in Greater Boston have unmet OTP access needs on public transit. Our results can inform decision-making to improve OTP access in Boston, such as increased early-morning transit service, expanding access to methadone beyond existing OTPs, or broadening non-emergent medical transit.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。